Business Opportunities and Investment Strategies for Global mRNA Therapeutics Market 2023-2033
Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global mRNA therapeutics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the mRNA therapeutics industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global mRNA therapeutics industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global mRNA therapeutics market is expected to reach $135.17 billion by 2033, growing by 16.1% annually over the coming years.
Segmentation Analysis
Highlighted with 89 tables and 92 figures, this 177-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, mRNA Type, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Product
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
This report focuses on identifying opportunities and strategies for investing in the global mRNA therapeutics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the mRNA therapeutics industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global mRNA therapeutics industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global mRNA therapeutics market is expected to reach $135.17 billion by 2033, growing by 16.1% annually over the coming years.
Segmentation Analysis
Highlighted with 89 tables and 92 figures, this 177-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, mRNA Type, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Product
- Prophylactic Vaccines
- Therapeutic Vaccines
- Therapeutic Drugs
- Self-amplifying mRNA
- Nucleoside-modified mRNA
- Unmodified mRNA
- Oncology
- Personalized Treatment
- Single Cancer Treatment
- Respiratory Diseases
- Infectious Diseases
- Autoimmune Diseases
- Rare Genetic Diseases
- Other Applications
- Hospitals and Clinics
- Research Organizations
- Other End Users
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Colombia, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, Israel, and Rest of MEA)
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
- Arcturus Therapeutics
- Argos Therapeutics Inc.
- AstraZeneca Plc
- BioNTech SE
- CRISPR Therapeutics AG
- CureVac AG
- eTheRNA
- Ethris GMBH
- GlaxoSmithKline PLC
- Moderna Therapeutics Inc.
- Pfizer Inc.
- Sangamo Therapeutics Inc.
- Translate Bio Inc.
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Prophylactic Vaccines
3.3 Therapeutic Vaccines
3.4 Therapeutic Drugs
4 SEGMENTATION OF GLOBAL MARKET BY MRNA TYPE
4.1 Market Overview by mRNA Type
4.2 Self-amplifying mRNA
4.3 Nucleoside-modified mRNA
4.4 Unmodified mRNA
5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
5.1 Market Overview by Application
5.2 Oncology
5.2.1 Personalized Treatment
5.2.2 Single Cancer Treatment
5.3 Respiratory Diseases
5.4 Infectious Diseases
5.5 Autoimmune Diseases
5.6 Rare Genetic Diseases
5.7 Other Applications
6 SEGMENTATION OF GLOBAL MARKET BY END USER
6.1 Market Overview by End User
6.2 Hospitals and Clinics
6.3 Research Organizations
6.4 Other End Users
7 SEGMENTATION OF GLOBAL MARKET BY REGION
7.1 Geographic Market Overview 2023-2033
7.2 North America Market 2023-2033 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2023-2033 by Country
7.3.1 Overview of European Market
7.3.2 Germany
7.3.3 U.K.
7.3.4 France
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2023-2033 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 Japan
7.4.3 China
7.4.4 Australia
7.4.5 India
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2023-2033 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Colombia
7.5.4 Rest of South America Market
7.6 MEA Market 2023-2033 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 Israel
7.6.4 Other National Markets
8 COMPETITIVE LANDSCAPE
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Arcturus Therapeutics
Argos Therapeutics Inc.
AstraZeneca Plc
BioNTech SE
CRISPR Therapeutics AG
CureVac AG
eTheRNA
Ethris GMBH
GlaxoSmithKline PLC
Moderna Therapeutics Inc.
Pfizer Inc.
Sangamo Therapeutics Inc.
Translate Bio Inc.
9 INVESTING IN MRNA THERAPEUTICS INDUSTRY: RISK ASSESSMENT AND MANAGEMENT
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT
3.1 Market Overview by Product
3.2 Prophylactic Vaccines
3.3 Therapeutic Vaccines
3.4 Therapeutic Drugs
4 SEGMENTATION OF GLOBAL MARKET BY MRNA TYPE
4.1 Market Overview by mRNA Type
4.2 Self-amplifying mRNA
4.3 Nucleoside-modified mRNA
4.4 Unmodified mRNA
5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION
5.1 Market Overview by Application
5.2 Oncology
5.2.1 Personalized Treatment
5.2.2 Single Cancer Treatment
5.3 Respiratory Diseases
5.4 Infectious Diseases
5.5 Autoimmune Diseases
5.6 Rare Genetic Diseases
5.7 Other Applications
6 SEGMENTATION OF GLOBAL MARKET BY END USER
6.1 Market Overview by End User
6.2 Hospitals and Clinics
6.3 Research Organizations
6.4 Other End Users
7 SEGMENTATION OF GLOBAL MARKET BY REGION
7.1 Geographic Market Overview 2023-2033
7.2 North America Market 2023-2033 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2023-2033 by Country
7.3.1 Overview of European Market
7.3.2 Germany
7.3.3 U.K.
7.3.4 France
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2023-2033 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 Japan
7.4.3 China
7.4.4 Australia
7.4.5 India
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2023-2033 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Colombia
7.5.4 Rest of South America Market
7.6 MEA Market 2023-2033 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 Israel
7.6.4 Other National Markets
8 COMPETITIVE LANDSCAPE
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Arcturus Therapeutics
Argos Therapeutics Inc.
AstraZeneca Plc
BioNTech SE
CRISPR Therapeutics AG
CureVac AG
eTheRNA
Ethris GMBH
GlaxoSmithKline PLC
Moderna Therapeutics Inc.
Pfizer Inc.
Sangamo Therapeutics Inc.
Translate Bio Inc.
9 INVESTING IN MRNA THERAPEUTICS INDUSTRY: RISK ASSESSMENT AND MANAGEMENT
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Global mRNA Therapeutics Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global mRNA Therapeutics Market
Table 8. Global mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 9. Global mRNA Therapeutics Market by mRNA Type, 2023-2033, $ mn
Table 10. Global mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 11. Global mRNA Therapeutics Market: Oncology by Type, 2023-2033, $ mn
Table 12. Global mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 13. Global mRNA Therapeutics Market by Region, 2023-2033, $ mn
Table 14. Leading National mRNA Therapeutics Market, 2023 and 2033, $ mn
Table 15. North America mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 16. U.S. mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 17. U.S. mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 18. U.S. mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 19. Canada mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 20. Canada mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 21. Canada mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 22. Mexico mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 23. Mexico mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 24. Mexico mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 25. Europe mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 26. Germany mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 27. Germany mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 28. Germany mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 29. U.K. mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 30. U.K. mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 31. U.K. mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 32. France mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 33. France mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 34. France mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 35. Spain mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 36. Spain mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 37. Spain mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 38. Italy mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 39. Italy mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 40. Italy mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 41. Russia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 42. Russia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 43. Russia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 44. mRNA Therapeutics Market in Rest of Europe by Country, 2023-2033, $ mn
Table 45. APAC mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 46. Japan mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 47. Japan mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 48. Japan mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 49. China mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 50. China mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 51. China mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 52. Australia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 53. Australia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 54. Australia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 55. India mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 56. India mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 57. India mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 58. South Korea mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 59. South Korea mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 60. South Korea mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 61. mRNA Therapeutics Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 62. South America mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 63. Argentina mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 64. Argentina mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 65. Argentina mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 66. Brazil mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 67. Brazil mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 68. Brazil mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 69. Colombia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 70. Colombia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 71. Colombia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 72. MEA mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 73. UAE mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 74. UAE mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 75. UAE mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 76. Saudi Arabia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 77. Saudi Arabia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 78. Saudi Arabia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 79. Israel mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 80. Israel mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 81. Israel mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 82. Breakdown of World Market by Key Vendor, 2023, %
Table 83. Arcturus Therapeutics: Company Snapshot
Table 84. Arcturus Therapeutics: Business Segmentation
Table 85. Arcturus Therapeutics: Product Portfolio
Table 86. List of Risk Factors and Weight Percentages/Theoretical Maximum
Table 87. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL)
Table 88. Risk Evaluation for Investing in Global Market, 2023-2033
Table 89. Critical Success Factors and Key Takeaways
Table 1. Snapshot of Global mRNA Therapeutics Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global mRNA Therapeutics Market
Table 8. Global mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 9. Global mRNA Therapeutics Market by mRNA Type, 2023-2033, $ mn
Table 10. Global mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 11. Global mRNA Therapeutics Market: Oncology by Type, 2023-2033, $ mn
Table 12. Global mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 13. Global mRNA Therapeutics Market by Region, 2023-2033, $ mn
Table 14. Leading National mRNA Therapeutics Market, 2023 and 2033, $ mn
Table 15. North America mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 16. U.S. mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 17. U.S. mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 18. U.S. mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 19. Canada mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 20. Canada mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 21. Canada mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 22. Mexico mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 23. Mexico mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 24. Mexico mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 25. Europe mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 26. Germany mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 27. Germany mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 28. Germany mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 29. U.K. mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 30. U.K. mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 31. U.K. mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 32. France mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 33. France mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 34. France mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 35. Spain mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 36. Spain mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 37. Spain mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 38. Italy mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 39. Italy mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 40. Italy mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 41. Russia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 42. Russia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 43. Russia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 44. mRNA Therapeutics Market in Rest of Europe by Country, 2023-2033, $ mn
Table 45. APAC mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 46. Japan mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 47. Japan mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 48. Japan mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 49. China mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 50. China mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 51. China mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 52. Australia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 53. Australia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 54. Australia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 55. India mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 56. India mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 57. India mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 58. South Korea mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 59. South Korea mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 60. South Korea mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 61. mRNA Therapeutics Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 62. South America mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 63. Argentina mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 64. Argentina mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 65. Argentina mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 66. Brazil mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 67. Brazil mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 68. Brazil mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 69. Colombia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 70. Colombia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 71. Colombia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 72. MEA mRNA Therapeutics Market by Country, 2023-2033, $ mn
Table 73. UAE mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 74. UAE mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 75. UAE mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 76. Saudi Arabia mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 77. Saudi Arabia mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 78. Saudi Arabia mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 79. Israel mRNA Therapeutics Market by Product, 2023-2033, $ mn
Table 80. Israel mRNA Therapeutics Market by Application, 2023-2033, $ mn
Table 81. Israel mRNA Therapeutics Market by End User, 2023-2033, $ mn
Table 82. Breakdown of World Market by Key Vendor, 2023, %
Table 83. Arcturus Therapeutics: Company Snapshot
Table 84. Arcturus Therapeutics: Business Segmentation
Table 85. Arcturus Therapeutics: Product Portfolio
Table 86. List of Risk Factors and Weight Percentages/Theoretical Maximum
Table 87. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL)
Table 88. Risk Evaluation for Investing in Global Market, 2023-2033
Table 89. Critical Success Factors and Key Takeaways
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Industry Value Chain Analysis
Figure 5. Global mRNA Therapeutics Market, 2023-2033, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global mRNA Therapeutics Market
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Global mRNA Therapeutics Market
Figure 11. Porter’s Fiver Forces Analysis of Global mRNA Therapeutics Market
Figure 12. Growth Opportunity Analysis by Product
Figure 13. Breakdown of Global mRNA Therapeutics Market by Product, 2023-2033, % of Revenue
Figure 14. Global Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%)
Figure 15. Global mRNA Therapeutics Market by Product: Prophylactic Vaccines, 2023-2033, $ mn
Figure 16. Global mRNA Therapeutics Market by Product: Therapeutic Vaccines, 2023-2033, $ mn
Figure 17. Global mRNA Therapeutics Market by Product: Therapeutic Drugs, 2023-2033, $ mn
Figure 18. Growth Opportunity Analysis by mRNA Type
Figure 19. Breakdown of Global mRNA Therapeutics Market by mRNA Type, 2023-2033, % of Sales Revenue
Figure 20. Global Addressable Market Cap in 2024-2033 by mRNA Type, Value ($ mn) and Share (%)
Figure 21. Global mRNA Therapeutics Market by mRNA Type: Self-amplifying mRNA, 2023-2033, $ mn
Figure 22. Global mRNA Therapeutics Market by mRNA Type: Nucleoside-modified mRNA, 2023-2033, $ mn
Figure 23. Global mRNA Therapeutics Market by mRNA Type: Unmodified mRNA, 2023-2033, $ mn
Figure 24. Growth Opportunity Analysis by Application
Figure 25. Breakdown of Global mRNA Therapeutics Market by Application, 2023-2033, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%)
Figure 27. Global mRNA Therapeutics Market by Application: Oncology, 2023-2033, $ mn
Figure 28. Global mRNA Therapeutics Market by Oncology: Personalized Treatment, 2023-2033, $ mn
Figure 29. Global mRNA Therapeutics Market by Oncology: Single Cancer Treatment, 2023-2033, $ mn
Figure 30. Global mRNA Therapeutics Market by Application: Respiratory Diseases, 2023-2033, $ mn
Figure 31. Global mRNA Therapeutics Market by Application: Infectious Diseases, 2023-2033, $ mn
Figure 32. Global mRNA Therapeutics Market by Application: Autoimmune Diseases, 2023-2033, $ mn
Figure 33. Global mRNA Therapeutics Market by Application: Rare Genetic Diseases, 2023-2033, $ mn
Figure 34. Global mRNA Therapeutics Market by Application: Other Applications, 2023-2033, $ mn
Figure 35. Growth Opportunity Analysis by End User
Figure 36. Breakdown of Global mRNA Therapeutics Market by End User, 2023-2033, % of Revenue
Figure 37. Global Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%)
Figure 38. Global mRNA Therapeutics Market by End User: Hospitals and Clinics, 2023-2033, $ mn
Figure 39. Global mRNA Therapeutics Market by End User: Research Organizations, 2023-2033, $ mn
Figure 40. Global mRNA Therapeutics Market by End User: Other End Users, 2023-2033, $ mn
Figure 41. Global Market Snapshot by Region
Figure 42. Growth Opportunity Analysis of Global Market by Region
Figure 43. Geographic Spread of Worldwide mRNA Therapeutics Market, 2023-2033, % of Sales Revenue
Figure 44. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 45. North American mRNA Therapeutics Market, 2023-2033, $ mn
Figure 46. Growth Opportunity Analysis of North America Market by Country
Figure 47. Breakdown of North America mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 48. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 49. U.S. mRNA Therapeutics Market, 2023-2033, $ mn
Figure 50. Canada mRNA Therapeutics Market, 2023-2033, $ mn
Figure 51. mRNA Therapeutics Market in Mexico, 2023-2033, $ mn
Figure 52. European mRNA Therapeutics Market, 2023-2033, $ mn
Figure 53. Growth Opportunity Analysis of Europe Market by Country
Figure 54. Breakdown of European mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 55. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 56. mRNA Therapeutics Market in Germany, 2023-2033, $ mn
Figure 57. mRNA Therapeutics Market in U.K., 2023-2033, $ mn
Figure 58. mRNA Therapeutics Market in France, 2023-2033, $ mn
Figure 59. mRNA Therapeutics Market in Spain, 2023-2033, $ mn
Figure 60. mRNA Therapeutics Market in Italy, 2023-2033, $ mn
Figure 61. mRNA Therapeutics Market in Russia, 2023-2033, $ mn
Figure 62. mRNA Therapeutics Market in Rest of Europe, 2023-2033, $ mn
Figure 63. Asia-Pacific mRNA Therapeutics Market, 2023-2033, $ mn
Figure 64. Growth Opportunity Analysis of Asia-Pacific Market by Country
Figure 65. Breakdown of APAC mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 66. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. mRNA Therapeutics Market in Japan, 2023-2033, $ mn
Figure 68. mRNA Therapeutics Market in China, 2023-2033, $ mn
Figure 69. mRNA Therapeutics Market in Australia, 2023-2033, $ mn
Figure 70. mRNA Therapeutics Market in India, 2023-2033, $ mn
Figure 71. mRNA Therapeutics Market in South Korea, 2023-2033, $ mn
Figure 72. mRNA Therapeutics Market in Rest of APAC, 2023-2033, $ mn
Figure 73. South America mRNA Therapeutics Market, 2023-2033, $ mn
Figure 74. Growth Opportunity Analysis of South America Market by Country
Figure 75. Breakdown of South America mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 76. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 77. mRNA Therapeutics Market in Argentina, 2023-2033, $ mn
Figure 78. mRNA Therapeutics Market in Brazil, 2023-2033, $ mn
Figure 79. mRNA Therapeutics Market in Colombia, 2023-2033, $ mn
Figure 80. mRNA Therapeutics Market in Rest of South America, 2023-2033, $ mn
Figure 81. mRNA Therapeutics Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 82. Growth Opportunity Analysis of MEA Market by Country
Figure 83. Breakdown of MEA mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 84. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 85. mRNA Therapeutics Market in UAE, 2023-2033, $ mn
Figure 86. mRNA Therapeutics Market in Saudi Arabia, 2023-2033, $ mn
Figure 87. mRNA Therapeutics Market in Israel, 2023-2033, $ mn
Figure 88. mRNA Therapeutics Market in the Rest of MEA, 2023-2033, $ mn
Figure 89. Growth Stage of Global mRNA Therapeutics Industry over the Forecast Period
Figure 90. Comparison of Risk Factors by GMD RIN in 2023
Figure 91. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart
Figure 92. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Industry Value Chain Analysis
Figure 5. Global mRNA Therapeutics Market, 2023-2033, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global mRNA Therapeutics Market
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Global mRNA Therapeutics Market
Figure 11. Porter’s Fiver Forces Analysis of Global mRNA Therapeutics Market
Figure 12. Growth Opportunity Analysis by Product
Figure 13. Breakdown of Global mRNA Therapeutics Market by Product, 2023-2033, % of Revenue
Figure 14. Global Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%)
Figure 15. Global mRNA Therapeutics Market by Product: Prophylactic Vaccines, 2023-2033, $ mn
Figure 16. Global mRNA Therapeutics Market by Product: Therapeutic Vaccines, 2023-2033, $ mn
Figure 17. Global mRNA Therapeutics Market by Product: Therapeutic Drugs, 2023-2033, $ mn
Figure 18. Growth Opportunity Analysis by mRNA Type
Figure 19. Breakdown of Global mRNA Therapeutics Market by mRNA Type, 2023-2033, % of Sales Revenue
Figure 20. Global Addressable Market Cap in 2024-2033 by mRNA Type, Value ($ mn) and Share (%)
Figure 21. Global mRNA Therapeutics Market by mRNA Type: Self-amplifying mRNA, 2023-2033, $ mn
Figure 22. Global mRNA Therapeutics Market by mRNA Type: Nucleoside-modified mRNA, 2023-2033, $ mn
Figure 23. Global mRNA Therapeutics Market by mRNA Type: Unmodified mRNA, 2023-2033, $ mn
Figure 24. Growth Opportunity Analysis by Application
Figure 25. Breakdown of Global mRNA Therapeutics Market by Application, 2023-2033, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%)
Figure 27. Global mRNA Therapeutics Market by Application: Oncology, 2023-2033, $ mn
Figure 28. Global mRNA Therapeutics Market by Oncology: Personalized Treatment, 2023-2033, $ mn
Figure 29. Global mRNA Therapeutics Market by Oncology: Single Cancer Treatment, 2023-2033, $ mn
Figure 30. Global mRNA Therapeutics Market by Application: Respiratory Diseases, 2023-2033, $ mn
Figure 31. Global mRNA Therapeutics Market by Application: Infectious Diseases, 2023-2033, $ mn
Figure 32. Global mRNA Therapeutics Market by Application: Autoimmune Diseases, 2023-2033, $ mn
Figure 33. Global mRNA Therapeutics Market by Application: Rare Genetic Diseases, 2023-2033, $ mn
Figure 34. Global mRNA Therapeutics Market by Application: Other Applications, 2023-2033, $ mn
Figure 35. Growth Opportunity Analysis by End User
Figure 36. Breakdown of Global mRNA Therapeutics Market by End User, 2023-2033, % of Revenue
Figure 37. Global Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%)
Figure 38. Global mRNA Therapeutics Market by End User: Hospitals and Clinics, 2023-2033, $ mn
Figure 39. Global mRNA Therapeutics Market by End User: Research Organizations, 2023-2033, $ mn
Figure 40. Global mRNA Therapeutics Market by End User: Other End Users, 2023-2033, $ mn
Figure 41. Global Market Snapshot by Region
Figure 42. Growth Opportunity Analysis of Global Market by Region
Figure 43. Geographic Spread of Worldwide mRNA Therapeutics Market, 2023-2033, % of Sales Revenue
Figure 44. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%)
Figure 45. North American mRNA Therapeutics Market, 2023-2033, $ mn
Figure 46. Growth Opportunity Analysis of North America Market by Country
Figure 47. Breakdown of North America mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 48. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 49. U.S. mRNA Therapeutics Market, 2023-2033, $ mn
Figure 50. Canada mRNA Therapeutics Market, 2023-2033, $ mn
Figure 51. mRNA Therapeutics Market in Mexico, 2023-2033, $ mn
Figure 52. European mRNA Therapeutics Market, 2023-2033, $ mn
Figure 53. Growth Opportunity Analysis of Europe Market by Country
Figure 54. Breakdown of European mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 55. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 56. mRNA Therapeutics Market in Germany, 2023-2033, $ mn
Figure 57. mRNA Therapeutics Market in U.K., 2023-2033, $ mn
Figure 58. mRNA Therapeutics Market in France, 2023-2033, $ mn
Figure 59. mRNA Therapeutics Market in Spain, 2023-2033, $ mn
Figure 60. mRNA Therapeutics Market in Italy, 2023-2033, $ mn
Figure 61. mRNA Therapeutics Market in Russia, 2023-2033, $ mn
Figure 62. mRNA Therapeutics Market in Rest of Europe, 2023-2033, $ mn
Figure 63. Asia-Pacific mRNA Therapeutics Market, 2023-2033, $ mn
Figure 64. Growth Opportunity Analysis of Asia-Pacific Market by Country
Figure 65. Breakdown of APAC mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 66. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 67. mRNA Therapeutics Market in Japan, 2023-2033, $ mn
Figure 68. mRNA Therapeutics Market in China, 2023-2033, $ mn
Figure 69. mRNA Therapeutics Market in Australia, 2023-2033, $ mn
Figure 70. mRNA Therapeutics Market in India, 2023-2033, $ mn
Figure 71. mRNA Therapeutics Market in South Korea, 2023-2033, $ mn
Figure 72. mRNA Therapeutics Market in Rest of APAC, 2023-2033, $ mn
Figure 73. South America mRNA Therapeutics Market, 2023-2033, $ mn
Figure 74. Growth Opportunity Analysis of South America Market by Country
Figure 75. Breakdown of South America mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 76. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 77. mRNA Therapeutics Market in Argentina, 2023-2033, $ mn
Figure 78. mRNA Therapeutics Market in Brazil, 2023-2033, $ mn
Figure 79. mRNA Therapeutics Market in Colombia, 2023-2033, $ mn
Figure 80. mRNA Therapeutics Market in Rest of South America, 2023-2033, $ mn
Figure 81. mRNA Therapeutics Market in Middle East and Africa (MEA), 2023-2033, $ mn
Figure 82. Growth Opportunity Analysis of MEA Market by Country
Figure 83. Breakdown of MEA mRNA Therapeutics Market by Country, 2023 and 2033, % of Revenue
Figure 84. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 85. mRNA Therapeutics Market in UAE, 2023-2033, $ mn
Figure 86. mRNA Therapeutics Market in Saudi Arabia, 2023-2033, $ mn
Figure 87. mRNA Therapeutics Market in Israel, 2023-2033, $ mn
Figure 88. mRNA Therapeutics Market in the Rest of MEA, 2023-2033, $ mn
Figure 89. Growth Stage of Global mRNA Therapeutics Industry over the Forecast Period
Figure 90. Comparison of Risk Factors by GMD RIN in 2023
Figure 91. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart
Figure 92. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart
